Cargando…

How to treat VAP due to MDR pathogens in ICU patients

BACKGROUND: The increasing occurrence of multidrug resistant (MDR) bacteria arises at a time when there is a lack of antibiotics active against these pathogens and few new antimicrobials are in the pipelines of the pharmaceutical industry. Treatment of ventilator-associated pneumonia (VAP) caused es...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garnacho-Montero, José, Corcia-Palomo, Yael, Amaya-Villar, Rosario, Martin-Villen, Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289192/ https://www.ncbi.nlm.nih.gov/pubmed/25430700 http://dx.doi.org/10.1186/1471-2334-14-135

Ejemplares similares

How to approach and treat VAP in ICU patients
por: Borgatta, Bárbara, et al.
Publicado: (2014)

Mortality of oncohematologic patients admitted to the intensive care unit (icu) who required invasive mechanical ventilation (imv). do we have to delay intubation?
por: Corcia Palomo, Y, et al.
Publicado: (2015)

Non-transplant patients with haematologic malignancies have better survival outcome than recipients of haematopoietic stem cell transplant (HSCT) after admission to intensive care unit (ICU)
por: Corcia Palomo, Y, et al.
Publicado: (2015)

Application of VAP bundles resulting in low incidence of VAP in ICU
por: Khan, FM, et al.
Publicado: (2011)

A validated clinical approach for the management of aspergillosis in critically ill patients: ready, steady, go!
por: Garnacho-Montero, Jose, et al.
Publicado: (2006)

Fatal MDR Klebsiella in ICU — How was it Dealt with?
por: Khandelwal, Vipul, et al.
Publicado: (2019)

Periodontitis leads to VAP in ICU patients: A dental note
por: Saini, Rajiv, et al.
Publicado: (2010)

Rapid Detection of Carbapenemase-Producing Multidrug-Resistant (MDR) Pathogens by Modified Carba NP Test in Ventilator-Associated Pneumonia (VAP) in Elderly Patients
por: Pasha S A, Rahil, et al.
Publicado: (2023)

Making Contact: VAP Targeting by Intracellular Pathogens
por: Murray, Rebecca, et al.
Publicado: (2018)

The vapB–vapC Operon of Acidovorax citrulli Functions as a Bona-fide Toxin–Antitoxin Module
por: Shavit, Reut, et al.
Publicado: (2016)

Correlation of VAP diagnosis with parameters of critically ill patients in a general ICU
por: Matthaiou, DK, et al.
Publicado: (2012)

Vaccinated Patients Admitted in ICU with Severe Pneumonia Due to SARS-CoV-2: A Multicenter Pilot Study
por: Estella, Ángel, et al.
Publicado: (2021)

Source of MDR infections in an ICU: busting the myth
por: Agrawal, R
Publicado: (2015)

In Silico Analysis of Genetic VapC Profiles from the Toxin-Antitoxin Type II VapBC Modules among Pathogenic, Intermediate, and Non-Pathogenic Leptospira
por: Lopes, Alexandre P. Y., et al.
Publicado: (2019)

Reduction in the incidence of VAP and mortality rates in the ICU after implementation of hand hygiene education protocols and extensive ICU reconstruction work
por: Filos, K, et al.
Publicado: (2011)

The influence of enteral feeding on ventilator associated pneumonia (VAP) in trauma mechanically ventilated patients in ICU
por: Djazmati, W, et al.
Publicado: (2001)

Assessment of knowledge and compliance to evidence-based guidelines for VAP prevention among ICU nurses in Tanzania
por: Bankanie, Vicent, et al.
Publicado: (2021)

Timing of antibiotic therapy in the ICU
por: Kollef, Marin H., et al.
Publicado: (2021)

Biomarker kinetics in the prediction of VAP diagnosis: results from the BioVAP study
por: Póvoa, Pedro, et al.
Publicado: (2016)

Biogeography of the fish pathogen Aeromonas salmonicida inferred by vapA genotyping
por: Gulla, Snorre, et al.
Publicado: (2019)

Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome
por: Garnacho-Montero, José, et al.
Publicado: (2005)

Use of a ventilator-associated pneumonia (VAP) bundle to decrease the VAP rate in Syria
por: Alsadat, R, et al.
Publicado: (2012)

Regulation of Enteric vapBC Transcription: Induction by VapC Toxin Dimer-Breaking
por: Winther, Kristoffer S., et al.
Publicado: (2012)

Prognostic differences between VAP from Acinetobacter baumanii and VAP from other microorganisms
por: Di Bonito, Marianna, et al.
Publicado: (2012)

Primary and secondary bacteremia caused by mdr bacteria in ICU patients
por: Pappa, E, et al.
Publicado: (2015)

The “Old” and the “New” Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How
por: Karaiskos, Ilias, et al.
Publicado: (2019)

Current place of probiotics for VAP
por: Virk, Harjeet Singh, et al.
Publicado: (2019)

What the VAP: The Expanded VAP Family of Proteins Interacting With FFAT and FFAT-Related Motifs for Interorganellar Contact
por: Neefjes, Jacques, et al.
Publicado: (2021)

Study of microbiological and antibiotic sensitivity pattern of ventilator associated pneumonia (VAP) in ICU of a tertiary care hospital in Nepal
por: Mishra, Deebya R., et al.
Publicado: (2020)

Effect of ICU quality control indicators on VAP incidence rate and mortality: a retrospective study of 1267 hospitals in China
por: Ding, Xin, et al.
Publicado: (2022)

Structure of the virulence-associated protein VapD from the intracellular pathogen Rhodococcus equi
por: Whittingham, Jean L., et al.
Publicado: (2014)

VAP Proteins – From Organelle Tethers to Pathogenic Host Interactors and Their Role in Neuronal Disease
por: Kors, Suzan, et al.
Publicado: (2022)

Comparative Genomics of Rhodococcus equi Virulence Plasmids Indicates Host-Driven Evolution of the vap Pathogenicity Island
por: MacArthur, Iain, et al.
Publicado: (2017)

Death by acid rain: VAP or EXIT?
por: Thorburn, Kentigern, et al.
Publicado: (2009)

The Interactome of the VAP Family of Proteins: An Overview
por: James, Christina, et al.
Publicado: (2021)

Adequate antibiotic therapy prior to ICU admission in patients with severe sepsis and septic shock reduces hospital mortality
por: Garnacho-Montero, José, et al.
Publicado: (2015)

Toxin-antitoxin loci vapBC-1 and vapXD contribute to survival and virulence in nontypeable Haemophilus influenzae
por: Ren, Dabin, et al.
Publicado: (2012)

Comparison of Morbidity, Mortality, and Costs of VAP Patients with Non-VAP Patients in the Tertiary Referral Hospital of Kerman, Iran
por: Ahmadipour, Maryam, et al.
Publicado: (2023)

Efficacy of probiotics in the prevention of VAP in critically ill ICU patients: an updated systematic review and meta-analysis of randomized control trials
por: Batra, Priyam, et al.
Publicado: (2020)

Detection of bacteria via multiplex PCR in respiratory samples of critically ill COVID-19 patients with suspected HAP/VAP in the ICU
por: Karolyi, Mario, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8s902sejama4lmjlhuhmutkimj